NYSE: KVUE
Consumer Defensive · Household & Personal Products
Market Cap
$34.79B
52w High
$22.87
52w Low
$14.02
P/E
21.47
Volume
32.06M
Outstanding Shares
1.92B
Price vs Fundamentals
The stock fell 15.17% over the last year. Revenue declined 0.07% over the trailing twelve months. Operating margin moved from 12.08% to 19.62%. Free cash flow grew 25.72% over the trailing twelve months.
Visible fundamentals weakened far less than the stock price, and the shares now sit around the 23rd percentile of their historical P/FCF range. That looks more like a rerating of the multiple than a collapse in the business.
This read changes if operating margin (currently 19.62%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Kenvue Inc. functions as a global leader in the consumer health sector.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
4
Buy
10
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 6, 2026
Q3 FY26 · EPS est $0.32 · Revenue est $3.96B
View
Dividends
$0.83/shareQuarterlyAdequateKVUE pays a dividend with a 4.58% dividend yield, covered 1.1× by free cash flow.
Dividend Yield
4.58%
Annual Div / Share
$0.83
CAGR
—
Payout Ratio
0.37%
Adequate
Dividend Growth Rate
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$4/mo
In 5 yrs
$4/mo
In 10 yrs
$4/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$46/yr $4/mo | $46/yr $4/mo | $46/yr $4/mo |